Please Wait.....
Report
Clinical Decision Support Platform Market By Component (Software, Services) , By Delivery Mode (On-Premises, Cloud Based) By Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders, Others) By End User (Hospitals, Clinics, Ambulatory Care Centers, Academic and Research Institutes) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
Clinical Decision Support Platform Market
The clinical decision support platform market was valued at $1.2 billion in 2023 and is projected to reach $2.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Clinical decision support platform is a system designed to enhance the delivery of healthcare by refining the decision-making process. The platform compares patient data & health records with the existing database & assessments and provides tailored recommendations. The aim of the platform is to elevate the quality of healthcare delivery through precise diagnoses, optimized treatment plans, reduced errors, and strict adherence to appropriate practices.
Increase in expenditure of healthcare and patient safety across different regions is driving the growth of the clinical decision support platform market. In addition, the clinical decision support platform is witnessing a high demand as it aids in cost savings by facilitating the optimal usage of resources and reducing the cases of unnecessary hospital readmissions. In the digital era, clinical decision support platforms powered by the properties of AI and deep learning are gaining prominence. AI enables the precise assessment and interpretation of loads of data in a short span of time. Moreover, deep learning complements the attributes of AI through predictive analysis, pattern analysis, and image recognition.
However, the installation and maintenance of the platform, along with the assembly of necessary resources & infrastructure is an expensive process that restraints the growth of the clinical decision support platform market. Furthermore, these platforms remain at a high risk of data breach and cyberattacks, which hampers the market development. For instance, Change Healthcare-an American healthcare company-was targeted to a ransomware attack on February 2024, risking the health data of millions of Americans due to unauthorized access.
Segment Review
The clinical decision support platform market is segmented into component, delivery mode, application, end user, and region. On the basis of component, the market is bifurcated into software and services. As per delivery mode, it is divided into on-premises and cloud based. Depending on application, it is classified into drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders, and others. By end user, it is categorized into hospitals, clinics, ambulatory care centers, and academic & research institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of component, the software segment dominated the market in 2023.
As per delivery mode, the on-premises segment acquired a high stake in the market in 2023.
Depending on application, the drug-drug interactions segment accounted for a high market share in 2023.
By end user, the hospitals segment was the highest shareholder of the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players of the global clinical decision support platform market include Cerner Corporation, EPIC Systems Corporation, IBM, Change Healthcare Corporation, Medical Information Technology Inc, Koninklijke Philips NV, Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, and McKesson Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- Reimbursement Scenario
Key Market Segments
By Component
- Software
- Services
By Delivery Mode
- On-Premises
- Cloud Based
By Application
- Drug Allergy Alerts
- Clinical Guidelines
- Drug-Drug Interactions
- Clinical Reminders
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Care Centers
- Academic and Research Institutes
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Cerner Corporation
- EPIC Systems Corporation
- IBM
- Change Healthcare Corporation
- Medical Information Technology Inc
- Koninklijke Philips NV
- Siemens Healthcare
- Allscripts Healthcare Solutions Inc.
- Wolters Kluwer NV
- McKesson Corporation.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Group Order Type
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Embodied Variant Type
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Reconstructed Information Type
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Mode of Delivery
5.2. On-Premises
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cloud-Based
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Web-Based
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Care Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Specialty Clinics
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Mode of Delivery
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Clinical Pathway Information System Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Mode of Delivery
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Clinical Pathway Information System Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Mode of Delivery
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Clinical Pathway Information System Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Mode of Delivery
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Mode of Delivery
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Clinical Pathway Information System Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Mode of Delivery
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Clinical Pathway Information System Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Mode of Delivery
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Clinical Pathway Information System Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Mode of Delivery
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Clinical Pathway Information System Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Mode of Delivery
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Clinical Pathway Information System Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Mode of Delivery
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Clinical Pathway Information System Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Mode of Delivery
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Mode of Delivery
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Clinical Pathway Information System Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Mode of Delivery
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Clinical Pathway Information System Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Mode of Delivery
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Clinical Pathway Information System Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Mode of Delivery
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Clinical Pathway Information System Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Mode of Delivery
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Clinical Pathway Information System Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Mode of Delivery
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Clinical Pathway Information System Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Mode of Delivery
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Mode of Delivery
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Clinical Pathway Information System Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Mode of Delivery
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Clinical Pathway Information System Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Mode of Delivery
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Clinical Pathway Information System Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Mode of Delivery
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Clinical Pathway Information System Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Mode of Delivery
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. McKesson Corporation
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Civica
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. GE Healthcare
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Koninklijke Philips N.V.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. EPIC Systems Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Optum, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. PointClickCare
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Cerner Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Philips Healthcare
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Athenahealth
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 2. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 5. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR ON-PREMISES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLOUD BASED, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 8. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR DRUG ALLERGY ALERTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICAL GUIDELINES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR DRUG-DRUG INTERACTIONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICAL REMINDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 14. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 18. CLINICAL DECISION SUPPORT PLATFORM MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 20. NORTH AMERICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 21. NORTH AMERICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 22. NORTH AMERICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. NORTH AMERICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. U.S. CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 25. U.S. CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 26. U.S. CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 27. U.S. CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. CANADA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 29. CANADA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 30. CANADA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 31. CANADA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. MEXICO CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 33. MEXICO CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 34. MEXICO CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. MEXICO CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 37. EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 38. EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 39. EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 40. EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. FRANCE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 42. FRANCE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 43. FRANCE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. FRANCE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. GERMANY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 46. GERMANY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 47. GERMANY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. GERMANY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. ITALY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 50. ITALY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 51. ITALY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 52. ITALY CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. SPAIN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 54. SPAIN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 55. SPAIN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 56. SPAIN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. UK CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 58. UK CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 59. UK CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. UK CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. REST OF EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 62. REST OF EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 63. REST OF EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 64. REST OF EUROPE CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 66. ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 67. ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 68. ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. CHINA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 71. CHINA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 72. CHINA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. CHINA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. JAPAN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 75. JAPAN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 76. JAPAN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 77. JAPAN CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. INDIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 79. INDIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 80. INDIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 81. INDIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH KOREA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH KOREA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 84. SOUTH KOREA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. SOUTH KOREA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. AUSTRALIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 87. AUSTRALIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 88. AUSTRALIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 89. AUSTRALIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 90. REST OF ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 91. REST OF ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 92. REST OF ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 93. REST OF ASIA-PACIFIC CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 94. LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 95. LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 96. LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 97. LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 98. LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 99. BRAZIL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 100. BRAZIL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 101. BRAZIL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 102. BRAZIL CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 103. SOUTH AFRICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 104. SOUTH AFRICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 105. SOUTH AFRICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 106. SOUTH AFRICA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 107. SAUDI ARABIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 108. SAUDI ARABIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 109. SAUDI ARABIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 110. SAUDI ARABIA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 111. REST OF LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 112. REST OF LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE, 2024 - 2033 ($BILLION)
TABLE 113. REST OF LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 114. REST OF LAMEA CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 115. CERNER CORPORATION: KEY EXECUTIVES
TABLE 116. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 117. CERNER CORPORATION: OPERATING SEGMENTS
TABLE 118. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 119. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 121. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 122. EPIC SYSTEMS CORPORATION: OPERATING SEGMENTS
TABLE 123. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 124. EPIC SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. IBM: KEY EXECUTIVES
TABLE 126. IBM: COMPANY SNAPSHOT
TABLE 127. IBM: OPERATING SEGMENTS
TABLE 128. IBM: PRODUCT PORTFOLIO
TABLE 129. IBM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. CHANGE HEALTHCARE CORPORATION: KEY EXECUTIVES
TABLE 131. CHANGE HEALTHCARE CORPORATION: COMPANY SNAPSHOT
TABLE 132. CHANGE HEALTHCARE CORPORATION: OPERATING SEGMENTS
TABLE 133. CHANGE HEALTHCARE CORPORATION: PRODUCT PORTFOLIO
TABLE 134. CHANGE HEALTHCARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. MEDICAL INFORMATION TECHNOLOGY INC: KEY EXECUTIVES
TABLE 136. MEDICAL INFORMATION TECHNOLOGY INC: COMPANY SNAPSHOT
TABLE 137. MEDICAL INFORMATION TECHNOLOGY INC: OPERATING SEGMENTS
TABLE 138. MEDICAL INFORMATION TECHNOLOGY INC: PRODUCT PORTFOLIO
TABLE 139. MEDICAL INFORMATION TECHNOLOGY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 140. KONINKLIJKE PHILIPS NV: KEY EXECUTIVES
TABLE 141. KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT
TABLE 142. KONINKLIJKE PHILIPS NV: OPERATING SEGMENTS
TABLE 143. KONINKLIJKE PHILIPS NV: PRODUCT PORTFOLIO
TABLE 144. KONINKLIJKE PHILIPS NV: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 145. SIEMENS HEALTHCARE: KEY EXECUTIVES
TABLE 146. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
TABLE 147. SIEMENS HEALTHCARE: OPERATING SEGMENTS
TABLE 148. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 149. SIEMENS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 150. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: KEY EXECUTIVES
TABLE 151. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: COMPANY SNAPSHOT
TABLE 152. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: OPERATING SEGMENTS
TABLE 153. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: PRODUCT PORTFOLIO
TABLE 154. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 155. WOLTERS KLUWER NV: KEY EXECUTIVES
TABLE 156. WOLTERS KLUWER NV: COMPANY SNAPSHOT
TABLE 157. WOLTERS KLUWER NV: OPERATING SEGMENTS
TABLE 158. WOLTERS KLUWER NV: PRODUCT PORTFOLIO
TABLE 159. WOLTERS KLUWER NV: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 160. MCKESSON CORPORATION.: KEY EXECUTIVES
TABLE 161. MCKESSON CORPORATION.: COMPANY SNAPSHOT
TABLE 162. MCKESSON CORPORATION.: OPERATING SEGMENTS
TABLE 163. MCKESSON CORPORATION.: PRODUCT PORTFOLIO
TABLE 164. MCKESSON CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF CLINICAL DECISION SUPPORT PLATFORM MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN CLINICAL DECISION SUPPORT PLATFORM MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLINICAL DECISION SUPPORT PLATFORM MARKET
FIGURE 10. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET SEGMENTATION, BY COMPONENT
FIGURE 11. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET SEGMENTATION, BY DELIVERY MODE
FIGURE 14. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR ON-PREMISES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLOUD BASED, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET SEGMENTATION, BY APPLICATION
FIGURE 17. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR DRUG ALLERGY ALERTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICAL GUIDELINES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR DRUG-DRUG INTERACTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICAL REMINDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. GLOBAL CLINICAL DECISION SUPPORT PLATFORM MARKET SEGMENTATION, BY END USER
FIGURE 23. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 26. CLINICAL DECISION SUPPORT PLATFORM MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 31. COMPETITIVE DASHBOARD
FIGURE 32. COMPETITIVE HEATMAP: CLINICAL DECISION SUPPORT PLATFORM MARKET
FIGURE 33. TOP PLAYER POSITIONING, 2023
FIGURE 34. CERNER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. CERNER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. CERNER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. EPIC SYSTEMS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. IBM: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. IBM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. IBM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. CHANGE HEALTHCARE CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. CHANGE HEALTHCARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. CHANGE HEALTHCARE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. MEDICAL INFORMATION TECHNOLOGY INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. MEDICAL INFORMATION TECHNOLOGY INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. MEDICAL INFORMATION TECHNOLOGY INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. KONINKLIJKE PHILIPS NV: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. KONINKLIJKE PHILIPS NV: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. KONINKLIJKE PHILIPS NV: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. SIEMENS HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. SIEMENS HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 58. WOLTERS KLUWER NV: NET SALES, 2021-2023 ($BILLION)
FIGURE 59. WOLTERS KLUWER NV: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 60. WOLTERS KLUWER NV: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 61. MCKESSON CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 62. MCKESSON CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 63. MCKESSON CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security